Organization
SCIderm Research Institute and Dermatologikum Hamburg, Hamburg, Germany
2 abstracts
Abstract
APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR: IMPROVEMENTS IN NAIL AND SCALP PSORIASIS AND PSORIASIS AREA AND SEVERITY INDEX IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS (ESTEEM 1 AND 2) Org: Probity Medical Research, Waterloo, Canada, Bakersfield Dermatology, Bakersfield, United States, Toulouse University, Hôpital Larrey, Toulouse, France, SKiN Centre for Dermatology, Peterborough, Canada, SCIderm Research Institute and Dermatologikum Hamburg, Hamburg, Germany,
Abstract
52-WEEK EFFICACY AND SAFETY OF APREMILAST AND SWITCH FROM ETANERCEPT IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS: RESULTS FROM THE LIBERATE STUDY Org: SCIderm Research Institute and Dermatologikum Hamburg, Hamburg, Germany, Southern California Dermatology, Santa Ana, United States, Skin Centre for Dermatology and Probity Medical Research, Peterborough, Canada, Celgene Corporation, Summit,